# Evaluation of the Safety, Tolerability, and Pharmacokinetics of J4 in Healthy Adults

> **NCT06938763** · PHASE1 · RECRUITING · sponsor: **Academia Sinica, Taiwan** · enrollment: 76 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** J4
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06938763
- **Lead sponsor:** Academia Sinica, Taiwan
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-14
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2026-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06938763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06938763, "Evaluation of the Safety, Tolerability, and Pharmacokinetics of J4 in Healthy Adults". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT06938763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*